Hla Loss

HLA Loss is a genetic alteration in tumor cells characterized by the downregulation or absence of human leukocyte antigen class I molecules, thereby impairing antigen presentation and enabling immune evasion.

310

Publications

23.7K

Citations

2.2K

Authors

603

Institutions

Publications per year

2017–2026

46

Variants

Human Leukocyte Antigen Loss

Authors

2.2K

  1. FG
    Federico Garrido

    Hospital Universitario Virgen de las Nieves, Spain

    46 publications · 2.9K citations

    31

    h-index

  2. FR
    Francisco Ruiz‐Cabello

    Hospital Universitario Virgen de las Nieves, Spain

    33 publications · 2.3K citations

    26

    h-index

  3. TC
    Teresa Cabrera

    Hospital Universitario Virgen de las Nieves, Spain

    20 publications · 1.3K citations

    18

    h-index

  4. SF
    Soldano Ferrone

    Massachusetts General Hospital, United States

    19 publications · 2K citations

    17

    h-index

  5. IM
    Isabel Maleno

    Hospital Universitario Virgen de las Nieves, Spain

    13 publications · 600 citations

    12

    h-index

1–5 of 2.2K

Venues

  1. International Journal of Cancer

    30 publications · 2.2K citations

    25

    h-index

  2. PubMed

    Repository · 33 publications · 1.5K citations

    24

    h-index

  3. Tissue Antigens

    20 publications · 1.1K citations

    17

    h-index

  4. Human Immunology

    16 publications · 585 citations

    13

    h-index

  5. Cancer Immunology Immunotherapy

    11 publications · 609 citations

    11

    h-index

1–5